Retatrutide 10mg | Triple Receptor Agonist | 99% Purity | Third-Party Tested

$135.00

Product Overview

Retatrutide (LY3437943) is a synthetic triple receptor agonist peptide with agonist activity at GLP-1, GIP, and glucagon receptors. This research-grade peptide has been extensively studied in laboratory settings for its unique triple receptor binding mechanism and comparative molecular properties relative to single and dual incretin agonists. Retatrutide is frequently researched alongside Semaglutide (single GLP-1 agonist) and Tirzepatide (dual GIP/GLP-1 agonist) in comparative incretin receptor research applications.

Our Retatrutide research peptide is manufactured to the highest standards, with third-party verified purity exceeding 99%. Each vial contains 10mg of lyophilized (freeze-dried) peptide powder, accompanied by a Certificate of Analysis (COA) from an independent laboratory.

Research Applications

Retatrutide has been the subject of numerous peer-reviewed studies examining its role as a triple receptor agonist. Research has focused on its molecular binding affinity to GLP-1, GIP, and glucagon receptors, comparative receptor selectivity analysis, and unique triple-agonist signaling mechanisms. Published studies have investigated Retatrutide’s molecular pathways in cell culture models and laboratory environments.

Research applications include:

  • Triple receptor binding studies: Examination of simultaneous GLP-1, GIP, and glucagon receptor interactions and binding kinetics in vitro
  • Comparative incretin research: Investigation of single versus dual versus triple agonist mechanisms, frequently studied alongside Semaglutide and Tirzepatide
  • Metabolic signaling pathways: Study of complex receptor cross-talk, cAMP production patterns, and integrated metabolic regulatory mechanisms
  • Peptide pharmacology analysis: Research into multi-receptor agonist design, molecular modifications, and structure-activity relationships

Important: This product is intended for laboratory research use only. It is not approved for human consumption, clinical use, or any diagnostic or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease.

Product Specifications

  • Peptide Name: Retatrutide
  • Alternative Names: LY3437943
  • Classification: Triple GLP-1/GIP/Glucagon Receptor Agonist
  • Molecular Weight: ~4800 g/mol (approximate)
  • Dosage per Vial: 10mg
  • Form: Lyophilized (freeze-dried) white powder
  • Purity: >99% (verified by third-party HPLC analysis)
  • Storage: Store lyophilized peptide at -20°C. After reconstitution, store at 2-8°C and use within 30 days for optimal stability.
  • Packaging: Sterile sealed vial with tamper-evident cap

Quality & Purity Guarantee

Every batch of our Retatrutide peptide undergoes rigorous third-party testing to ensure maximum purity and quality:

  • HPLC Analysis: High-Performance Liquid Chromatography confirms peptide purity >99%
  • Mass Spectrometry: Verifies molecular weight and sequence accuracy
  • Certificate of Analysis: Each order includes a COA from an independent, accredited laboratory
  • Sterility Testing: Ensures product is free from microbial contamination
  • Endotoxin Testing: Confirms safe levels for research applications

We are committed to providing researchers with the highest quality peptides for advancing scientific knowledge.

Frequently Asked Questions

What is Retatrutide?

Retatrutide (LY3437943) is a synthetic triple receptor agonist peptide with agonist activity at GLP-1, GIP, and glucagon receptors. It has been extensively studied in preclinical research settings for its unique molecular properties enabling simultaneous activation of three metabolic receptor pathways, making it valuable for comparative incretin research.

What is Retatrutide used for in research?

Retatrutide is used in laboratory research to study triple receptor agonist mechanisms, comparative metabolic pathway activation, and complex receptor signaling. Research applications include multi-receptor binding assays, comparative studies with single-agonists (Semaglutide) and dual-agonists (Tirzepatide), and metabolic signaling cascade analysis. This product is for research purposes only and is not intended for human consumption.

How should Retatrutide be stored?

Store lyophilized Retatrutide at -20°C (freezer) for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C (refrigerator) and use within 30 days for optimal stability. Avoid repeated freeze-thaw cycles to maintain peptide integrity and molecular stability.

Does each vial come with a Certificate of Analysis?

Yes, every batch of our Retatrutide peptide is tested by an independent, third-party laboratory. Each order includes access to the Certificate of Analysis (COA) verifying purity, molecular weight, and quality specifications through HPLC and mass spectrometry analysis.

How does Retatrutide compare to Semaglutide and Tirzepatide in research?

Retatrutide, Semaglutide, and Tirzepatide are frequently studied together in comparative research. Semaglutide is a selective GLP-1 agonist, Tirzepatide is a dual GIP/GLP-1 agonist, and Retatrutide is a triple GLP-1/GIP/Glucagon agonist. This allows researchers to examine progressive receptor activation patterns, differential metabolic pathway engagement, and comparative molecular mechanisms. All research should be conducted in controlled laboratory environments by qualified personnel.

What makes Retatrutide unique as a research peptide?

Retatrutide represents an advanced multi-receptor agonist design with simultaneous activity at three distinct metabolic receptors (GLP-1, GIP, and glucagon). This unique pharmacological profile enables research into complex receptor cross-talk, integrated metabolic regulatory systems, and the progressive effects of single → dual → triple agonist mechanisms in comparative studies.

Research Disclaimer

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

This product is sold exclusively for research and laboratory purposes. Retatrutide is not approved by the FDA for human use, clinical applications, or any diagnostic or therapeutic purposes when sold as a research peptide. This product is not intended to diagnose, treat, cure, or prevent any disease. Researchers should follow all applicable laws, regulations, and institutional guidelines when handling this material.

By purchasing this product, you acknowledge that you are a qualified researcher or acting on behalf of a research institution, and that this peptide will be used solely for in-vitro or laboratory research purposes.

Related Research Peptides

Researchers studying Retatrutide may also be interested in these complementary peptides:

Subscribe to recive the latest news.

85% of users stay updated with our newsletter.

Sign up & get 10% off for your next purchase.




    Retatrutide 10mg | Triple Receptor Agonist | 99% Purity | Third-Party Tested
    Retatrutide 10mg | Triple Receptor Agonist | 99% Purity | Third-Party Tested